Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1993-4-22
|
| pubmed:language |
dut
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0302-6469
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
54
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
599-610
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:1296405-Belgium,
pubmed-meshheading:1296405-Cost-Benefit Analysis,
pubmed-meshheading:1296405-Diffusion of Innovation,
pubmed-meshheading:1296405-Drug Design,
pubmed-meshheading:1296405-Health Priorities,
pubmed-meshheading:1296405-Humans,
pubmed-meshheading:1296405-Patents as Topic,
pubmed-meshheading:1296405-Research,
pubmed-meshheading:1296405-Vaccination,
pubmed-meshheading:1296405-Vaccines
|
| pubmed:year |
1992
|
| pubmed:articleTitle |
[Biomedical research: cost-benefit analysis].
|
| pubmed:publicationType |
Journal Article
|